As per the WHO, worldwide nearly 1.71 billion people have a Musculoskeletal Condition. “Musculoskeletal conditions are also the biggest contributor to years lived with disability (YLDs) worldwide accounting for 17% of all YLDs worldwide”. Musculoskeletal Disorders often result in very high absenteeism, lost productivity, functioning, and a degraded quality of life.
Some of the most common types of Musculoskeletal Disorders are Chronic Low back pain, Carpal Tunnel Syndrome, Rheumatoid Arthritis, Tendonitis/Tendinitis, Osteoarthritis, Fibromyalgia, Bone Fractures, Gout, Neck Pain, Dupuytren Contractures, Frozen Shoulder (Adhesive Capsulitis), and others.
The Global Prevalence of Musculoskeletal Disorders is increasing at a significant pace due to various factors such as the growing older population, sedentary lifestyle, ergonomic factors (such as lifting, awkward working postures, and pushing or pulling), and many others.
However, to reduce the growing burden, some of the leading companies in the Musculoskeletal Disorders Market such as Braeburn Pharmaceuticals, Camurus, Regeneron Pharmaceuticals, Teva Pharmaceutical, Eli Lilly and Company, Mesoblast, Egalet Corporation, Axsome Therapeutics, Allodynic Therapeutics, Astellas Pharma, Grünenthal GmbH, Frontier Biotechnologies, DiscGenics, Semnur Pharmaceuticals, Stayble Therapeutics, AnGes MG, Novartis, Bristol-Myers Squibb, Teva Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals, GlaxoSmithKline, Taisho Pharmaceutical, R-Pharm, Bone Therapeutics, and several others are actively involved in the development of innovative products.
For more details, visit Pharmaceutical Companies in Musculoskeletal Disorders Market